ag-1296 has been researched along with Ewing Sarcoma in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uren, A | 1 |
| Merchant, MS | 1 |
| Sun, CJ | 1 |
| Vitolo, MI | 1 |
| Sun, Y | 1 |
| Tsokos, M | 1 |
| Illei, PB | 1 |
| Ladanyi, M | 1 |
| Passaniti, A | 1 |
| Mackall, C | 1 |
| Toretsky, JA | 1 |
1 other study available for ag-1296 and Ewing Sarcoma
| Article | Year |
|---|---|
Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Topics: Animals; Becaplermin; Bone Neoplasms; Cell Division; Chemotaxis; Class Ib Phosphatidylinositol 3-Kin | 2003 |